Publication: Human Papillomavirus 16 E2 as an Apoptosis-Inducing Protein for Cancer Treatment: A Systematic Review
dc.contributor.author | Dinah Farhanah Jamal | en_US |
dc.contributor.author | Quratul Ain Rozaimee | en_US |
dc.contributor.author | Nadila Haryani Osman | en_US |
dc.contributor.author | Atikah Mohd Sukor | en_US |
dc.contributor.author | Marjanu Hikmah Elias | en_US |
dc.contributor.author | Nor Aripin Shamaan | en_US |
dc.contributor.author | Srijit Das | en_US |
dc.contributor.author | Nazefah Abdul Hamid | en_US |
dc.date.accessioned | 2024-05-28T04:30:40Z | |
dc.date.available | 2024-05-28T04:30:40Z | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022-10-25 | |
dc.description | Int. J. Mol. Sci. 2022, 23(20), | en_US |
dc.description.abstract | Human papillomavirus type 16 (HPV-16) is a well-known etiological factor for cervical and oropharyngeal cancers. The E2 protein, the product of an early-transcribed gene in HPV–16, is postulated to cause the death of cancerous cells via p53-dependent and p53-independent pathways. The main aim of the present systematic review was to study the HPV 16-E2 protein as an apoptosis-inducer agent. A thorough search of MEDLINE/PubMed, Science Direct, Scopus, and EBSCOhost databases was conducted for relevant studies on HPV AND apoptosis OR cell death where HPV 16-E2 was involved. The search identified 967 publications. Eleven records dated from 1 January 1997 to 16 February 2022 were found to meet the inclusion criteria and were eligible for data extraction and inclusion. All studies concluded that HPV 16-E2 was able to induce cell death in transfected cells. E2 proteins from the high-risk HPV–16 were able to induce apoptosis through different apoptotic pathways depending on the location of the expressed gene. However, the mechanism was still unclear, and further studies are warranted. | en_US |
dc.identifier.citation | Jamal, D.F.; Rozaimee, Q.A.; Osman, N.H.; Mohd Sukor, A.; Elias, M.H.; Shamaan, N.A.; Das, S.; Abdul Hamid, N. Human Papillomavirus 16 E2 as an Apoptosis-Inducing Protein for Cancer Treatment: A Systematic Review. Int. J. Mol. Sci. 2022, 23, 12554. https://doi.org/10.3390/ijms232012554 | en_US |
dc.identifier.doi | 10.3390/ijms232012554 | |
dc.identifier.epage | 17 | |
dc.identifier.issn | 1422-0067 | |
dc.identifier.issue | 20 | |
dc.identifier.other | 444-24 | |
dc.identifier.spage | 1 | |
dc.identifier.uri | https://www.mdpi.com/1422-0067/23/20/12554 | |
dc.identifier.uri | https://oarep.usim.edu.my/handle/123456789/5785 | |
dc.identifier.volume | 23 | |
dc.language.iso | en | en_US |
dc.publisher | MDPI | en_US |
dc.relation.ispartof | International Journal of Molecular Sciences | en_US |
dc.subject | apoptosis; cell death; E2 protein; human papillomavirus; HPV 16 | en_US |
dc.title | Human Papillomavirus 16 E2 as an Apoptosis-Inducing Protein for Cancer Treatment: A Systematic Review | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Human Papillomavirus 16 E2 as an Apoptosis-Inducing Protein for Cancer Treatment A Systematic Review.pdf
- Size:
- 1.15 MB
- Format:
- Adobe Portable Document Format